CDMX.- The Ministry of Economy (SE) and the firm Novartis Mexico signed a document this Wednesday that establishes that the Swiss pharmaceutical company will make an investment of 50 million dollars in the next years.
In a joint statement, both parties reported that the signature was given through a memorandum of understanding. for cooperation in economic reactivation and health promotion and investment in the country, this being these common objectives for both parties.
The 50 million dollars of investment will be directed to promote actions of clinical research, as well as an update of the quality laboratory of this leading health company.
Read more: US Senate demands that Mexico comply with T-MEC agreements in the agroindustrial sector
In addition, the coordination of actions will be articulated during the next five years, in four strategic pillars: internal market, employment and company; promotion and investment facilities international trade and regionalization and sectors
The signing of the document was made by the Undersecretary of Industry and Commerce, Héctor Guerrero, and the president of Novartis Mexico, Fernando Cruz.
The SE pointed out that these actions are the result of an extensive work program that permanently seeks to boost the competitiveness and digitization of the industry and support micro, small, medium and large companies.
In addition to facilitating and improving procedures, promoting national and foreign investment, promoting Mexico’s foreign trade and cooperation for the development of priority and strategic high-impact sectors for the creation of jobs in the country.
Read more: In 2021 gasoline increased to 3 pesos per liter in Mexico: CRE
The Economic Commission for Latin America and the Caribbean (Cepal) pointed out this Wednesday that Mexico received 21,432 million dollars than Mexico from foreign direct investment (FDI) from January to September 2021, 8.5% more than the same period of 2020 .